Skip to Main Navigation
Skip to Page Content
Share This:
https://ntp.niehs.nih.gov/go/iccvamforum-2018

ICCVAM Public Forum: May 2018

Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): advancing alternatives to animal testing

May 24, 2018
William H. Natcher Conference Center
National Institutes of Health
Bethesda, Maryland, USA

Final agenda

Videocast recording on NIH VideoCasting and Podcasting website
Approximately 4 hrs 30 min – requires Adobe Flash installed and Java Script enabled

ICCVAM’s goals include promotion of national and international partnerships between governmental and nongovernmental groups, including academia, industry, advocacy groups, and other key stakeholders. To foster these partnerships ICCVAM holds annual public forums to share information and facilitate direct communication of ideas and suggestions from stakeholders.

At this meeting, nearly 40 attendees and about 60 webcast viewers heard presentations by ICCVAM members on current activities related to the development and validation of alternative test methods and approaches. ICCVAM member agencies providing updates on activities included the Food and Drug Administration (FDA), the Environmental Protection Agency (EPA), the Department of Defense, the Department of Agriculture, the Department of the Interior, the National Institute of Standards and Technology, and the National Institutes of Health (NIH). Suzanne Fitzpatrick, FDA, and Gino Scarano, EPA, described strategic plans developed by their agencies to promote the use of non-animal methods, while Rick Paules, acting chief of the NTP Biomolecular Screening Branch, described the updated Tox21 strategic plan and goals for the program’s next five years.

A main focus of this meeting was implementation of the strategic roadmap for establishing new approaches to evaluate the safety of chemicals and medical products in the United States. NICEATM Deputy Director Nicole Kleinstreuer summarized ongoing implementation activities in the areas of skin sensitization and acute systemic toxicity, while Jill Merrill, FDA, described activities relevant to skin and eye irritation testing. Public comments submitted to the meeting focused largely on the strategic roadmap. Commenters offered suggestions on specific actions that should be taken to advance the goals of the strategic roadmap, and encouraged agencies that have been less active in ICCVAM activities to take a greater role.

Federal Register notice announcing the meeting (April 6, 2018) - View notice as webpage

Presentations

Welcome from ICCVAM Co-chairs: Anna Lowit, Environmental Protection Agency (EPA) and Emily Reinke, Department of Defense (DoD)

U.S. Strategic Roadmap for Alternative Approaches

International Activities: Nicole Kleinstreuer, NIEHS

FDA Updates

Tox21 Update: Richard Paules, NIEHS

EPA Updates

Department of Defense: Emily Reinke, DoD

Department of Agriculture: Carol Clarke, USDA

Department of the Interior: Barnett Rattner, Department of the Interior

National Institute of Standards and Technology: Elijah Petersen, National Institute of Standards and Technology

National Institutes of Health: Warren Casey, NIEHS

Public Comments

People for the Ethical Treatment of Animals (May 11)

Physicians Committee for Responsible Medicine (May 11)

White Coat Waste Project/New England Anti-Vivisection Society (May 17)
Supplemental documentation

The Humane Society of the United States (May 24)